Utynam's Heirs


A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449

diary@managingip.com

The drug that dare not speak its name

Utynam was pleased to receive a piece of news from a Chinese law firm about Pfizer's recent victory in a Beijing court over a patent related to its anti-impotence drug Viagra.

In an email accompanying a press release prepared by Peksung, which advised Pfizer in its long-running dispute with a group of Chinese companies over the patent, the sender informed Utynam that "a decision was made today by Beijing Higher Court regarding the Chinese patent on Pfizer's popular drug".

Utynam thought little more of Peksung's enigmatic refusal to name its client's blockbuster drug until he sent a reply thanking the firm for its timely update on developments in the Viagra case. The email bounced back having been rejected by the firm's electronic gatekeepers for containing a banned keyword.

Utynam is intrigued to know how Pfizer's in-house...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Jay Z fights lawsuit over his use of the word 'oh' in Run This Town http://t.co/QEgd8BYVLC via @guardian

Sep 17 2014 04:54 ·  reply ·  retweet ·  favourite
ManagingIP profile

Preview of #AIPPI2015 in Rio at #AIPPI2014 General Assembly. Who's going? http://t.co/jWNX2fpRg0

Sep 17 2014 04:46 ·  reply ·  retweet ·  favourite
ManagingIP profile

@Isabelle_Chabot Fly-catcher.

Sep 17 2014 04:41 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPPI Congress News 2014

Read this year's AIPPI Congress News - published daily by Managing IP direct from the AIPPI Annual Meeting in Toronto
null null null

September 2014

The surprising rise of the PTAB

Patent owners have been shocked at how popular IPR proceedings at the PTAB have proven. As the USPTO mulls over changes and the Federal Circuit braces itself for a deluge of appeals, Michael Loney reports on how the PTAB is likely to evolve



Most read articles

Supplements